LNTH vs PATH
Lantheus Holdings Inc (LNTH) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Lantheus Holdings Inc (LNTH) is a drug manufacturers - specialty & generic company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported LNTH revenue for 2024-12-31 was $1.53B. Net income was $312.4M. Revenue was up 18.3% from 2023-12-31 to 2024-12-31. LNTH currently screens at market cap $5.56B and trailing P/E 22.9.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
LNTH currently screens at market cap $5.56B and trailing P/E 22.9. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the LNTH and PATH stock pages for the full models.
Not investment advice.